Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Oye Therapeutics Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 1 distinct examiner and 1 distinct art unit. The portfolio shows a singular point of contact for current prosecution activities.
Examiner CHICKS, ASHLI ARIANA is identified as the busiest examiner, overseeing 1 pending office action. Because this examiner handles the only active matter, the prosecution strategy is currently tied to a single individual's review. This concentration in 1 distinct art unit indicates a specific technical focus.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
| CHICKS, ASHLI ARIANA | 1 | 60.6% | +50.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034142 | Caffeine Compositions | GONZALEZ, LUISALBERTO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034142 | Caffeine Compositions | GONZALEZ, LUISALBERTO | — |
| 17784375 | Caffeine Citrate Formulations | CHICKS, ASHLI ARIANA | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18034142 | Caffeine Compositions | GONZALEZ, LUISALBERTO | 1624 | §102§103Other | Non-Final OA | — | Pending | Apr 27, 2023 |
| 17784375 | Caffeine Citrate Formulations | CHICKS, ASHLI ARIANA | 1626 | §112DP | Final Rejection | — | Pending | Jun 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial